ATP1B4
gene geneOn this page
Summary
ATP1B4 (ATPase Na+/K+ transporting family member beta 4, HGNC:808) is a protein-coding gene on chromosome Xq24, encoding Protein ATP1B4 (Q9UN42). May act as a transcriptional coregulator during muscle development through its interaction with SNW1.
This gene has been found in all vertebrate genomes sequenced to date. However, this gene has undergone a change in function in placental mammals compared to other species. Specifically, in fish, avian, and amphibian species, this gene encodes plasma membrane-bound beta-subunits of Na,K-ATPase. In placental mammals, the encoded protein interacts with the nuclear transcriptional coregulator SKIP and may be involved in the regulation of TGF-beta signaling. Two transcript variants encoding different isoforms have been found for this gene.
Source: NCBI Gene 23439 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 76 total — 1 pathogenic
- MANE Select transcript:
NM_001142447
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:808 |
| Approved symbol | ATP1B4 |
| Name | ATPase Na+/K+ transporting family member beta 4 |
| Location | Xq24 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000101892 |
| Ensembl biotype | protein_coding |
| OMIM | 301073 |
| Entrez | 23439 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 8 protein_coding
ENST00000218008, ENST00000361319, ENST00000539306, ENST00000955249, ENST00000955250, ENST00000955251, ENST00000955252, ENST00000955253
RefSeq mRNA: 2 — MANE Select: NM_001142447
NM_001142447, NM_012069
CCDS: CCDS14598, CCDS48158
Canonical transcript exons
ENST00000218008 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000675744 | 120366525 | 120366789 |
| ENSE00000675745 | 120370715 | 120370843 |
| ENSE00000675746 | 120371106 | 120371210 |
| ENSE00000675748 | 120375372 | 120375568 |
| ENSE00000675749 | 120376380 | 120376436 |
| ENSE00000675751 | 120378678 | 120378773 |
| ENSE00003844628 | 120379473 | 120383237 |
| ENSE00003846344 | 120362089 | 120362231 |
Expression profiles
Bgee: expression breadth broad, 60 present calls, max score 97.31.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 1.1612 / max 233.1638, expressed in 135 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 197424 | 1.0682 | 132 |
| 197423 | 0.0930 | 26 |
Top tissues by expression
256 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 97.31 | gold quality |
| biceps brachii | UBERON:0001507 | 95.07 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 94.88 | gold quality |
| vastus lateralis | UBERON:0001379 | 89.92 | gold quality |
| quadriceps femoris | UBERON:0001377 | 88.19 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 87.44 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 86.74 | gold quality |
| diaphragm | UBERON:0001103 | 84.78 | silver quality |
| deltoid | UBERON:0001476 | 84.53 | gold quality |
| skeletal muscle organ | UBERON:0014892 | 84.19 | gold quality |
| muscle organ | UBERON:0001630 | 84.18 | gold quality |
| gastrocnemius | UBERON:0001388 | 82.92 | gold quality |
| muscle of leg | UBERON:0001383 | 82.40 | gold quality |
| gluteal muscle | UBERON:0002000 | 82.27 | gold quality |
| body of tongue | UBERON:0011876 | 81.90 | gold quality |
| triceps brachii | UBERON:0001509 | 81.40 | gold quality |
| muscle tissue | UBERON:0002385 | 79.29 | gold quality |
| tibialis anterior | UBERON:0001385 | 77.92 | silver quality |
| tongue | UBERON:0001723 | 69.74 | gold quality |
| buccal mucosa cell | CL:0002336 | 69.05 | silver quality |
| superior surface of tongue | UBERON:0007371 | 61.45 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 59.49 | gold quality |
| pancreatic ductal cell | CL:0002079 | 56.55 | silver quality |
| decidua | UBERON:0002450 | 56.55 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 56.35 | silver quality |
| jejunum | UBERON:0002115 | 55.84 | gold quality |
| lower lobe of lung | UBERON:0008949 | 53.56 | silver quality |
| hair follicle | UBERON:0002073 | 53.38 | gold quality |
| synovial joint | UBERON:0002217 | 53.02 | gold quality |
| ileal mucosa | UBERON:0000331 | 52.16 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.26 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
204 targeting ATP1B4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-29B-3P | 100.00 | 73.18 | 1833 |
| HSA-MIR-29C-3P | 100.00 | 73.15 | 1833 |
| HSA-MIR-29A-3P | 100.00 | 73.11 | 1835 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-6851-5P | 100.00 | 65.63 | 1294 |
| HSA-MIR-3689D | 100.00 | 66.14 | 1181 |
| HSA-MIR-6740-5P | 100.00 | 65.64 | 932 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-188-3P | 100.00 | 68.76 | 1240 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-4789-5P | 99.98 | 70.76 | 2721 |
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
| HSA-MIR-568 | 99.98 | 69.86 | 2084 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
Literature-anchored findings (GeneRIF, showing 1)
- variant in the coding region of the ATP1B4 gene may play little or no role in the development of PD in Chinese Han population. (PMID:24420862)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | atp1b4 | ENSDARG00000053262 |
| mus_musculus | Atp1b4 | ENSMUSG00000016327 |
| rattus_norvegicus | Atp1b4 | ENSRNOG00000007059 |
Paralogs (4): ATP1B3 (ENSG00000069849), ATP1B2 (ENSG00000129244), ATP1B1 (ENSG00000143153), ATP4B (ENSG00000186009)
Protein
Protein identifiers
Protein ATP1B4 — Q9UN42 (reviewed: Q9UN42)
Alternative names: X,K-ATPase subunit beta-m, X/potassium-transporting ATPase subunit beta-m
All UniProt accessions (2): Q9UN42, B7ZKW0
UniProt curated annotations — full annotation on UniProt →
Function. May act as a transcriptional coregulator during muscle development through its interaction with SNW1. Has lost its ancestral function as a Na,K-ATPase beta-subunit.
Subunit / interactions. Associates with a SMAD7-transcriptional complex. Interacts with SNW1 and TOR1AIP1. According to PubMed:17592128, does not associate with known Na,K-ATPase alpha-subunits.
Subcellular location. Nucleus inner membrane.
Tissue specificity. Highly expressed in skeletal muscle and at a lower level in heart.
Similarity. Belongs to the X(+)/potassium ATPases subunit beta family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9UN42-1 | A | yes |
| Q9UN42-2 | B |
RefSeq proteins (2): NP_001135919, NP_036201 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000402 | Na/K_ATPase_sub_beta | Family |
| IPR038702 | Na/K_ATPase_sub_beta_sf | Homologous_superfamily |
Pfam: PF00287
UniProt features (8 total): topological domain 2, chain 1, transmembrane region 1, region of interest 1, compositionally biased region 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9UN42-F1 | 81.54 | 0.54 |
Function
Pathways and Gene Ontology
Reactome pathways
8 pathways
| ID | Pathway |
|---|---|
| R-HSA-2173795 | Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| R-HSA-162582 | Signal Transduction |
| R-HSA-170834 | Signaling by TGF-beta Receptor Complex |
| R-HSA-212436 | Generic Transcription Pathway |
| R-HSA-2173793 | Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
| R-HSA-73857 | RNA Polymerase II Transcription |
| R-HSA-74160 | Gene expression (Transcription) |
| R-HSA-9006936 | Signaling by TGFB family members |
MSigDB gene sets: 144 (showing top):
GOBP_POTASSIUM_ION_TRANSPORT, REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX, TGCTGCT_MIR15A_MIR16_MIR15B_MIR195_MIR424_MIR497, RORA1_01, CAGCTG_AP4_Q5, GOBP_MONOATOMIC_CATION_TRANSPORT, PAX8_B, HFH8_01, FOXJ2_01, HFH4_01, HFH3_01, HFH1_01, E2F1_Q3, CCAGGGG_MIR331, FREAC7_01
GO Biological Process (5): regulation of DNA-templated transcription (GO:0006355), potassium ion transport (GO:0006813), sodium ion transport (GO:0006814), monoatomic ion transport (GO:0006811), transmembrane transport (GO:0055085)
GO Molecular Function (2): obsolete inorganic cation transmembrane transporter activity (GO:0022890), protein binding (GO:0005515)
GO Cellular Component (6): nuclear envelope (GO:0005635), nuclear inner membrane (GO:0005637), plasma membrane (GO:0005886), sodium:potassium-exchanging ATPase complex (GO:0005890), nucleus (GO:0005634), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-7 pathways:
| Category | Pathways |
|---|---|
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | 1 |
| Signaling by TGFB family members | 1 |
| RNA Polymerase II Transcription | 1 |
| Signaling by TGF-beta Receptor Complex | 1 |
| Generic Transcription Pathway | 1 |
| Gene expression (Transcription) | 1 |
| Signal Transduction | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| metal ion transport | 2 |
| transport | 2 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cellular process | 1 |
| binding | 1 |
| nucleus | 1 |
| endomembrane system | 1 |
| organelle envelope | 1 |
| organelle inner membrane | 1 |
| nuclear membrane | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cation-transporting ATPase complex | 1 |
| plasma membrane protein complex | 1 |
| intracellular membrane-bounded organelle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
866 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ATP1B4 | ZNF275 | Q9NSD4 | 523 |
| ATP1B4 | ATP1A2 | P50993 | 461 |
| ATP1B4 | ATP1A4 | Q13733 | 431 |
| ATP1B4 | OR8H1 | Q8NGG4 | 419 |
| ATP1B4 | PIP4K2C | Q8TBX8 | 405 |
| ATP1B4 | ATP1A3 | P13637 | 401 |
| ATP1B4 | OR6N1 | Q8NGY5 | 391 |
| ATP1B4 | ATP5MK | Q96IX5 | 380 |
| ATP1B4 | C1orf105 | O95561 | 370 |
| ATP1B4 | OR13F1 | Q8NGS4 | 366 |
| ATP1B4 | ATP13A3 | Q9H7F0 | 360 |
| ATP1B4 | ATP1A1 | P05023 | 359 |
| ATP1B4 | TMEM255A | Q5JRV8 | 353 |
| ATP1B4 | GCDH | Q92947 | 353 |
| ATP1B4 | OR10A5 | Q9H207 | 352 |
IntAct
26 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ERMP1 | ATP1B4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMIM3 | ATP1B4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TSPAN2 | ATP1B4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CSGALNACT2 | ATP1B4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CXCL9 | ATP1B4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TTMP | ATP1B4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ASGR1 | ATP1B4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| Snw1 | ATP1B4 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ATP1B4 | SYNGR3 | psi-mi:“MI:0914”(association) | 0.350 |
| ATP1B4 | TMEM131L | psi-mi:“MI:0914”(association) | 0.350 |
| TTMP | ATP1B4 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ASGR1 | ATP1B4 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ERMP1 | ATP1B4 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SMIM3 | ATP1B4 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TSPAN2 | ATP1B4 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CSGALNACT2 | ATP1B4 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CXCL9 | ATP1B4 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (92): EMC1 (Affinity Capture-MS), ATP1A4 (Affinity Capture-MS), HLA-A (Affinity Capture-MS), SCAP (Affinity Capture-MS), ITPRIP (Affinity Capture-MS), PTK7 (Affinity Capture-MS), SPPL2B (Affinity Capture-MS), POMT1 (Affinity Capture-MS), POMT2 (Affinity Capture-MS), TMEM59L (Affinity Capture-MS), GLB1L2 (Affinity Capture-MS), PGAP1 (Affinity Capture-MS), MGRN1 (Affinity Capture-MS), TMEM67 (Affinity Capture-MS), RTN2 (Affinity Capture-MS)
ESM2 similar proteins: A7MB71, A8X4W9, F8W463, O73798, O97827, P05029, P15127, P15208, P18434, P18597, P18598, P21188, P25169, P30715, P30716, P33704, P33879, P43002, P49654, P50992, P51164, P51578, P54709, P56373, P97370, Q202B1, Q24046, Q3T0C6, Q3UR32, Q60489, Q63377, Q64663, Q6DE92, Q6UX71, Q80TS3, Q8IUK5, Q91VE2, Q93086, Q93235, Q99572
Diamond homologs: A5A6J8, A7MB71, P05026, P05027, P05028, P05029, P06583, P07340, P08251, P13638, P14094, P14231, P14415, P18434, P18597, P18598, P21188, P25169, P30715, P30716, P33704, P33879, P43002, P51165, P54709, P97370, Q202B1, Q24046, Q28030, Q2HZ96, Q3T0C6, Q4R4V5, Q5J583, Q5R8S8, Q60489, Q63377, Q8WMG3, Q99ME6, Q9BDK6, Q9GLC3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
76 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 54 |
| Likely benign | 7 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1341314 | GRCh37/hg19 Xq24-25(chrX:119173583-126584360)x2 | Pathogenic |
SpliceAI
1693 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:120362227:GACTC:G | donor_gain | 1.0000 |
| X:120362232:G:GG | donor_gain | 1.0000 |
| X:120366651:G:GT | donor_gain | 1.0000 |
| X:120366657:G:GT | donor_gain | 1.0000 |
| X:120366666:G:GT | donor_gain | 1.0000 |
| X:120370746:T:G | acceptor_gain | 1.0000 |
| X:120373051:G:GT | donor_gain | 1.0000 |
| X:120378675:CAGAG:C | acceptor_gain | 1.0000 |
| X:120378676:AGAGA:A | acceptor_gain | 1.0000 |
| X:120378677:GA:G | acceptor_gain | 1.0000 |
| X:120378677:GAGA:G | acceptor_gain | 1.0000 |
| X:120378677:GAGAG:G | acceptor_gain | 1.0000 |
| X:120378774:G:GG | donor_gain | 1.0000 |
| X:120362187:TCCAG:T | donor_gain | 0.9900 |
| X:120362216:T:G | donor_gain | 0.9900 |
| X:120362228:ACTC:A | donor_gain | 0.9900 |
| X:120362228:ACTCG:A | donor_loss | 0.9900 |
| X:120362229:CTC:C | donor_gain | 0.9900 |
| X:120362229:CTCGT:C | donor_loss | 0.9900 |
| X:120362230:TC:T | donor_gain | 0.9900 |
| X:120362230:TCGT:T | donor_loss | 0.9900 |
| X:120362231:CGTGA:C | donor_loss | 0.9900 |
| X:120362232:GTGA:G | donor_loss | 0.9900 |
| X:120362233:TGAGT:T | donor_loss | 0.9900 |
| X:120362234:GAGTG:G | donor_loss | 0.9900 |
| X:120365803:C:G | donor_gain | 0.9900 |
| X:120366515:ACT:A | acceptor_gain | 0.9900 |
| X:120366517:T:A | acceptor_gain | 0.9900 |
| X:120366520:TCCAG:T | acceptor_loss | 0.9900 |
| X:120366521:CCAGG:C | acceptor_loss | 0.9900 |
AlphaMissense
2376 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:120375473:T:C | F222L | 1.000 |
| X:120375475:T:A | F222L | 1.000 |
| X:120375475:T:G | F222L | 1.000 |
| X:120379545:T:A | C329S | 1.000 |
| X:120379546:G:C | C329S | 1.000 |
| X:120371205:T:C | L186P | 0.999 |
| X:120375467:T:A | C220S | 0.999 |
| X:120375468:G:A | C220Y | 0.999 |
| X:120375468:G:C | C220S | 0.999 |
| X:120375474:T:C | F222S | 0.999 |
| X:120375474:T:G | F222C | 0.999 |
| X:120375497:T:A | C230S | 0.999 |
| X:120375498:G:A | C230Y | 0.999 |
| X:120375498:G:C | C230S | 0.999 |
| X:120375521:T:C | F238L | 0.999 |
| X:120375523:T:A | F238L | 0.999 |
| X:120375523:T:G | F238L | 0.999 |
| X:120375527:T:G | Y240D | 0.999 |
| X:120375545:T:A | C246S | 0.999 |
| X:120375545:T:C | C246R | 0.999 |
| X:120375546:G:A | C246Y | 0.999 |
| X:120375546:G:C | C246S | 0.999 |
| X:120375547:C:G | C246W | 0.999 |
| X:120376425:T:A | C269S | 0.999 |
| X:120376425:T:C | C269R | 0.999 |
| X:120376426:G:A | C269Y | 0.999 |
| X:120376426:G:C | C269S | 0.999 |
| X:120379507:T:C | F316S | 0.999 |
| X:120379545:T:C | C329R | 0.999 |
| X:120379612:T:C | F351S | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000057342 (X:120368028 A>G), RS1000135478 (X:120376230 T>C), RS1000256260 (X:120380499 A>G), RS1000401172 (X:120373551 C>G,T), RS1000411030 (X:120373765 A>G), RS1000496999 (X:120361568 G>C,T), RS1000736303 (X:120375022 A>T), RS1000742963 (X:120375314 C>T), RS1000848189 (X:120378769 C>T), RS1000950093 (X:120367862 A>G,T), RS1000992348 (X:120382859 T>A), RS1001062133 (X:120360725 C>A), RS1001297351 (X:120367604 A>G), RS1001398379 (X:120371877 C>T), RS1001449398 (X:120372161 T>C)
Disease associations
OMIM: gene MIM:301073 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008159_55 | Waist-to-hip ratio adjusted for BMI | 3.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007788 | BMI-adjusted waist-hip ratio |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| methylmercuric chloride | decreases expression | 1 |
| pirinixic acid | affects binding, decreases expression, increases activity | 1 |
| bisphenol A | decreases methylation | 1 |
| sodium arsenite | affects methylation | 1 |
| 2,7-dihydroxynaphthalene | decreases expression | 1 |
| incobotulinumtoxinA | decreases expression | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Fulvestrant | decreases methylation | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Etoposide | increases expression | 1 |
| Vanadium | decreases expression | 1 |
| Coal Ash | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.